Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Carlos Zagoya"'
Autor:
Jochen G. Mainz, Anton Barucha, Pu Huang, Lilith Bechinger, Franziska Duckstein, Louise Polte, Pauline Sadrieh, Lutz Nährlich, Olaf Eickmeier, Suzanne Van Dullemen, Patience Eschenhagen, Carsten Schwarz, Stefan Lüth, Carlos Zagoya, Ute Graepler-Mainka
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Elexacaftor–tezacaftor–ivacaftor (ETI) is a novel, highly effective CFTR modulator combination proven to enhance lung function and body weight in people with cystic fibrosis (pwCF) carrying a F508del mutation. Recently, we revealed si
Externí odkaz:
https://doaj.org/article/658abcaaf09940f9aee5d184e373a9e4
Autor:
Jochen G. Mainz, Carlos Zagoya, Louise Polte, Lutz Naehrlich, Lenny Sasse, Olaf Eickmeier, Christina Smaczny, Anton Barucha, Lilith Bechinger, Franziska Duckstein, Ludwik Kurzidim, Patience Eschenhagen, Laura Caley, Daniel Peckham, Carsten Schwarz
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/fdf445ccbf604305b8dbc4b1e0461e15
Autor:
Nina Erdmann, Theresa Schilling, Julia Hentschel, Thomas Lehmann, Philipp von Bismarck, Tobias Ankermann, Franziska Duckstein, Michael Baier, Carlos Zagoya, Jochen G. Mainz
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundIn cystic fibrosis (CF), acute respiratory exacerbations critically enhance pulmonary destruction. Since these mainly occur outside regular appointments, they remain unexplored. We previously elaborated a protocol for home-based upper airwa
Externí odkaz:
https://doaj.org/article/6c849df7704e4e46b11e0d5daf61a42f
Autor:
Jochen G. Mainz, Carlos Zagoya, Louise Polte, Lutz Naehrlich, Lenny Sasse, Olaf Eickmeier, Christina Smaczny, Anton Barucha, Lilith Bechinger, Franziska Duckstein, Ludwik Kurzidim, Patience Eschenhagen, Laura Caley, Daniel Peckham, Carsten Schwarz
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: The novel and highly effective CFTR modulator combination of elexacaftor-tezacaftor-ivacaftor (ETI) has been shown to improve lung function and body weight in people with Cystic Fibrosis (pwCF) carrying a F508del mutation. However, the im
Externí odkaz:
https://doaj.org/article/463ecbf462624e5c9175afeacb5af8f4
Autor:
Harold Tabori, Jochen Schneider, Stefan Lüth, Carlos Zagoya, Anton Barucha, Thomas Lehmann, Eberhard Kauf, Astrid Barth, Jochen G. Mainz
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 20, p 12436 (2022)
Hepatobiliary involvement is a hallmark in cystic fibrosis (CF), as the causative CF Transmembrane Conductance Regulator (CFTR) defect is expressed in the biliary tree. However, bile acid (BA) compositions in regard to pancreatic insufficiency, which
Externí odkaz:
https://doaj.org/article/d81423af9a064987b5397228eb36cf3b
Autor:
Jochen G. Mainz, Christin Arnold, Kara Wittstock, Uta-Christina Hipler, Thomas Lehmann, Carlos Zagoya, Franziska Duckstein, Helmut Ellemunter, Julia Hentschel
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
In cystic fibrosis (CF) therapy, the recent approval of CF-transmembrane conductance regulator (CFTR) channel modulators is considered to be the major breakthrough. However, the current first-line approach based mainly on pulmonary function to measur
Externí odkaz:
https://doaj.org/article/26142fae98294a3784e6ff40faf9c3e1
Publikováno v:
ERJ Open Research, Vol 7, Iss 2 (2021)
Externí odkaz:
https://doaj.org/article/f89ce776d08e4f85af561a36e1101842
Publikováno v:
New Journal of Physics, Vol 14, Iss 9, p 093050 (2012)
With the recently introduced concept of dominant interaction Hamiltonians, we construct numerically as well as analytically the spectrum of high harmonics (HH) generated in electron–ion scattering under an intense laser field. This is achieved by s
Externí odkaz:
https://doaj.org/article/802a7930e86d44d6a41b23e7ec26b2af
Autor:
Elizete Aparecida Lomazi, Marina Abib Stefano, Franziska Duckstein, Jochen G Mainz, Natascha Silva Sandy, Carlos Zagoya, Antonio Fernando Ribeiro
Publikováno v:
Journal of Cystic Fibrosis. 21:497-501
Publikováno v:
Expert review of respiratory medicine. 16(7)
Airway infection with pathogens and its associated pulmonary exacerbations (PEX) are the major causes of morbidity and premature death in cystic fibrosis (CF). Preventing or postponing chronic infections requires early diagnosis. However, limitations